News
FDA Approves Israeli Cancer-Freezing Technology
IceCure’s cancer-freezing technology relies on an innovative process referred to as cryoablation therapy.
Israeli healthtech companies and researchers have developed many life-saving technologies, some of which are now used in hospitals around the world. One highly promising medical technology has just been approved by the United States Food and Drug Administration (FDA) after demonstrating its ability to eliminate tumors using new cancer-freezing technology.
The groundbreaking technology comes from a healthtech company called IceCure. The company was founded in 2006, and it’s currently headquartered in the coastal city of Caesarea, Israel.
IceCure’s cancer-freezing technology relies on an innovative process referred to as cryoablation therapy. The goal of cryoablation is to insert a hollow needle into the breast until the tumor is reached. Liquid nitrogen is then precisely applied directly into a tumor to kill the abnormal tissue by freezing it at a very low temperature of -170°C (-274 F).
“We are basically covering the tissue with an ice ball. No tissue can survive such a low temperature,” explained Tlalit Bussi Tel-Tzure, vice president of business development and global marketing at IceCure. “Once the tissue is dead, it will dissolve in the body in a natural process and be absorbed in the body in a couple of weeks.”
The technology has already proved to be extremely successful when it comes to destroying kidney tumors, demonstrating perfect efficiency. Its main advantage is the fact that it can be carried out either at a doctor’s office or an outpatient facility thanks to its minimally invasive nature. The entire procedure can take less than one hour from start to finish, and it doesn’t leave any lasting physical mark on the body.
Also Read: Israelis Have Successfully Grown Mouse Embryos In Artificial Wombs
“Our main vision is to become the gold standard in breast cancer treatment,” said Eyal Shamir, CEO of IceCure Medical. “Most of the cases where you have good early detection are small tumors, considered early stage, and the only treatment available today is surgery.”
IceCure isn’t the only company exploring the application of cryoablation for treating breast cancer. There’s also California-based Sanarus Technologies, which has recently completed a clinical trial in the United States.
News
Noon And Yango Switch On Robot Deliveries In Dubai
The rollout folds autonomous couriers into noon’s rapid-delivery network as the UAE tests everyday autonomy.
Noon and Yango Group have signed an agreement to put autonomous robot deliveries into commercial use in Dubai, turning Yango’s earlier pilots into a daily service for noon Minutes orders. The launch in Sobha Hartland is the first full integration of Yango Autonomy’s electric robots with a major e-commerce network in the region, with wider deployment planned across Dubai and, later, other GCC markets.
Residents can choose a robot at checkout, track it in the app and unlock its compartment once it arrives. The hardware runs on Yango’s AI navigation and routing stack, which plans paths, avoids obstacles and yields to pedestrians. The units had already covered more than 1,500 kilometers during previous Dubai pilots, a test bed that demonstrated their ability to operate in mixed pedestrian environments and dense residential streets.
The rollout adds a contactless option to noon’s last-mile network and is positioned as extra capacity during peak periods. “Partnering with Yango Group lets us bring a future-ready delivery option straight to our customers,” said Ali Kafil-Hussain, noon’s Chief Business Officer. Noon has used Minutes to set rapid-delivery expectations in UAE cities; autonomous units now slot into that same high-frequency model.
Regulatory clearance from Dubai’s Roads and Transport Authority underpins the move. The RTA authorized Yango’s robots to operate on public walkways and in neighborhoods, smoothing the shift from controlled trials to commercial work. Dubai has framed autonomous mobility as part of its smart-city buildout, and the partners lean on that agenda to accelerate integration.
Also Read: Uber And WeRide Roll Out Driverless Robotaxis In Abu Dhabi
For Yango, the partnership is an anchor for its autonomy platform in the Gulf. Islam Abdul Karim, Yango’s Middle East regional head, said the aim is to make autonomous delivery an “everyday, reliable service” for UAE communities. The company views operational data from early districts as the basis for scaling into more communities and, eventually, cross-border rollouts.
The move lands as Gulf retailers search for faster fulfilment and lower-emission logistics. Autonomous couriers remain a small share of last-mile delivery, but Dubai’s approvals and early usage data give the partners a clearer path to turn pilots into durable infrastructure.
Noon And Yango Switch On Robot Deliveries In Dubai
botim money & Binance Weigh UAE Path For Regulated Crypto Access
Kalshi Secures $1 Billion As Prediction Markets Race Heats Up
Uber And WeRide Roll Out Driverless Robotaxis In Abu Dhabi
Cartlow Rolls Out Subscription Model For GCC Retail Platform
Emirates Airline To Roll Out Free Starlink Wi-Fi This Month
Spotify Tests Three-Tier Premium Push In UAE And Saudi Arabia
Dorsey-Backed diVine Brings Back Vine’s Looping Videos
Aramco Installs Middle East’s First Industrial Quantum Computer
